AA
FBT icon

AlphaMark Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

AlphaMark Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10
Closed -$1K – 509
2017
Q2 		$1K Buy
+10
New +$1.07K ﹤0.01% 510

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $392M AUM 21.9% 1-Year Est. Return

AlphaMark Advisors's FBT Position: Q3 2017 in Review

AlphaMark Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2017, closing a stake of 10 shares — an estimated $1K sold.

AlphaMark Advisors first reported a position in FBT in Q2 2017 and held it in 1 quarter. The position peaked at $1K in Q2 2017. 116 funds tracked by Wall St. Rank hold FBT as of Q3 2017.

  • AlphaMark Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2017 after selling out during the quarter.
  • AlphaMark Advisors sold 10 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2017, an estimated $1K.
  • AlphaMark Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 1 quarter.
  • AlphaMark Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1K in Q2 2017.
  • 116 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2017.

Based on AlphaMark Advisors's 13F filing for Q3 2017, filed 2 Nov 2017.